期刊文献+

下调microRNA-214表达对人卵巢癌SKOV-3细胞迁移及侵袭的影响

Effect of down-regulating microRNA-214 expression on migration and invasion of ovarian carcinoma SKOV-3 cells
原文传递
导出
摘要 目的:探讨下调microRNA-214(miR-214)表达对人卵巢癌SKOV-3细胞迁移和侵袭的作用及其可能机制。方法:采用脂质体介导法将miR-214抑制剂转染人卵巢癌SKOV-3细胞,Real-time PCR法检测miR-214、核因子-κB(nuclear factor-κB,NF-κB)和尿激酶型纤溶酶原激活剂(uridylyl phosphate adenosine,u PA)基因mRNA的表达,Western blotting法检测细胞NF-κB和u PA蛋白表达。划痕试验检测细胞迁移能力,Transwell小室法检测细胞侵袭能力。结果:经转染miR-214抑制剂后,人卵巢癌SKOV-3细胞miR-214表达降低,细胞迁移和侵袭能力降低。同时NF-κB和u PA mRNA和蛋白表达也降低。结论:下调人卵巢癌SKOV-3细胞miR-214表达可抑制细胞迁移和侵袭能力,下凋NF-κB和u PA基因表达可能是其作用机制。 Objective: To observe effect of down-regulating microRNA-214( miR-214) expression on migration and invasion of ovarian carcinoma SKOV-3 cells and explore its possible mechanism. Methods: miR-214 inhibitors were transfected into human ovarian carcinoma SKOV-3 cells by liposome. Expressions of miR-214,nuclear factor-κB( NF-κB) and urokinase-type plasminogen activator( uridylyl phosphate adenosine [u PA]) gene mRNA,as well as NF-κB and u PA proteins in the cells were respectively detected by Real-time PCR and Western blotting assays. Scarification test and transwell assay were used to detect abilities of migration and invasion of the cells respectively. Results: After transfection of miR-214 inhibitor,expression of miR-214 in human carcinoma SKOV-3 cells decreased,and migration and invasion abilities of the cells reduced. At the same time,expressions of NF-κB and u PA gene mRNA and proteins also depressed. Conclusion: Down-regulation of miR-214 expression in human ovarian carcinoma SKOV-3 cells could inhibit migration and invasion abilities of the cells,and down-regulation of NF-κB and u PA gene expressions might be its possible mechanism.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2016年第4期506-509,共4页 Chinese Journal of Cancer Biotherapy
基金 武警后勤学院创新团队课题资助(No.whtd2013-2)~~
关键词 卵巢癌 微小RNA-214 迁移 侵袭 ovarian cancer microRNA-214 migration invasion
  • 相关文献

参考文献12

  • 1YANG H, KONG W, HE L, et al. microRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cispl- atin resistance by targeting PTEN [ J ]. Cancer Res, 2008, 68 (2):425-433. DOI: 10.1158/0008-5472. CAN-07-2488.
  • 2BARTEL D P. MicroRNAs : target recognition and regulatory func- tions [J]. Cell, 2009, 136(2): 215-233. DOI: 10. 1016/j. cell. 2009.01. 002.
  • 3WANG X, CHEN S, LI F, et al. miR-214 inhibits cell growth in hepatocellular carcinoma through suppression of 13-catenin [ J ]. Biochem Biophy Res Commun, 2012, 428 (4) : 525-531. DOI: 10. 1016/j. bbrc. 2012.10. 039.
  • 4MISIEWICS-KRZEMINSKA I, SARASQUETE M E, QUWAIDER D, et al. Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of p53 and inhibition of DNA replication [ J]. Heamatologica, 2012, 98 (4) : 640-648. DOI: 10. 3324/haematol. 2012. 070011.
  • 5PENG R Q, WAN H Y, LI H F, et al. MicroRNA-21g suppresses growth and invasiveness of cervical cancer ceils by targeting UDR- N-acetyl-cL-d-galactosamine : polypeptide N-acetylgalactosaminyl- transferase 7 [J]. J Biol Chem, 2012, 287(17) : 14301-14309. DOI : 10. 107d/jbc. ml 11. 337642.
  • 6DERFOUL A, JUAN A H, DIFILIPPANTONIO A J, et al. De- creased microRNA-214 levels in breast cancer ceils coincides with increased cell proliferation, invasion and accumulation of the Poly- comb Ezh2 methyltransferase [ J ]. Carcinogenesis, 2011, 32 ( 11 ) : 1607-1614. DOI: 10. 1093/carcin/bgr184.
  • 7HUANG S D, YUAN Y, ZHANG C W, et al. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma [J/OL]. Mol Cancer, 2012, 11 ( 1 ) : 51[-2015-11-01]. http://molecular-cancer, biomedcentral, corn/ articles/10. 1186/14764598-11-51. DOI: 10. 1186/14764598- 11-51.
  • 8ZHANG X J, YE H, ZENG C W, et al. Dysregulation of miR-15a and miR-214 in human pancreatic cancer [J/OL]. J Hematol Oncol, 2010, 3 ( 1 ) : 46 [ 2015-11-01 ]. http://jhoonline. biomedcentral, corn/articles/10.1186/1756-8722-346. DOI: 10. 1186/1756-8722-3- 46.
  • 9潘其壮,覃展偶.uPA系统与肿瘤的研究进展[J].医学综述,2010,16(14):2140-2143. 被引量:8
  • 10AI-HASSAN N N, BEHZADLAU A, CALDWELL P, et al. Differ- ential roles of uPAR in peritoneal ovarian carcinomatosis [ J]. Neo- plasia, 2012, 14(4) : 259-270. DOI: 10. 1593/neo. 12442.

二级参考文献28

  • 1陈伟,陈谦学,王军民,郭熙雄,吴立权.NF-κB和uPA在人脑胶质瘤中的表达[J].中国临床神经外科杂志,2007,12(2):83-85. 被引量:4
  • 2O'TooleS,McGuinness E,Sheppared B,et al. Plasninogen activators and inhibitors in ovarian ademocarinomas[J].Int Gynecol Caner, 1999,9(1):61.
  • 3Tecimer C, Doering DL, Goldsmith LJ, et al. Chnical relevance of urokinase-type plasminogen activator, its receptor and inhibitor typel in ovarianc ancer[J]. Int J Gynecol Cancer, 2000,10(5) : 372.
  • 4Choong PF,Nadesapillai AP.Urokinase plasminogen activator system:a multifunctional role in tumor progression and metastasis[J].Clin Orthop Relat Res,2003(415 Suppl):S46-S58.
  • 5Crippa MP.Urokinase-type plasminogen activator[J].Int J Biochem Cell Bio,2007,39(4):690-694.
  • 6de Bock CE,Lin Z,Itoh T,et al.Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells[J].FEBS J,2005,272(14):3572-3582.
  • 7Pierga JY,Bonneton C,Magdelénat H,et al.Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor(uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients[J].Int J Cancer,2005,114(2):291-298.
  • 8Harbeck N,Kates RE,Schmitt M,et al.Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer[J].Clin Breast Cancer,2004,5(5):348-352.
  • 9Meng S,Tripathy D,Shete S,et al.uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues[J].Proc Natl Acad Sci USA,2006,103(46):17361-17365.
  • 10Minisini AM,Fabbro D,Di Loreto C,et al.Markers of the uPA system and common prognostic factors in breast cancer[J].Am J Clin Pathol,2007,128(1):112-117.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部